A Rigorous Framework for Automated Design Assessment and Type I Error Control: Methods and Demonstrative Examples (Working Paper)

12/20/2022
by   James Yang, et al.
0

We present a proof-by-simulation framework for rigorously controlling a trial design's operating characteristics over continuous regions of parameter space. We show that proof-by-simulation can achieve two major goals: (1) Calibrate a design for provable Type I Error control at a fixed level alpha. (2) Given a fixed design, bound (with high probability) its operating characteristics, such as the Type I Error, FDR, or bias of bounded estimators. This framework can handle adaptive sampling, nuisance parameters, administrative censoring, multiple arms, and multiple testing. These techniques, which we call Continuous Simu lation Extension (CSE), were first developed in Sklar (2021) to control Type I Error and FWER for designs where unknown parameters have exponential family likelihood. Our appendix improves those results with more efficient bounding and calibration methods, extends them to general operating characteristics including FDR and bias, and extends applicability to include canonical GLMs and some non-parametric problems. In the main paper we demonstrate our CSE approach and software on 3 examples (1) a gentle introduction, analyzing the z-test (2) a hierarchical Bayesian analysis of 4 treatments, with sample sizes fixed (3) an adaptive Bayesian Phase II-III selection design with 4 arms, where interim dropping and go/no-go decisions are based on a hierarchical model. Trillions of simulations were performed for the latter two examples, enabled by specialized INLA software. Open-source software is maintained at (1)

READ FULL TEXT

page 12

page 14

page 15

research
05/24/2021

Approximating the Operating Characteristics of Bayesian Uncertainty Directed Trial Designs

Bayesian response adaptive clinical trials are currently evaluating expe...
research
03/18/2021

A unified framework for weighted parametric group sequential design (WPGSD)

Group sequential design (GSD) is widely used in clinical trials in which...
research
07/09/2020

Adding experimental treatment arms to Multi-Arm Multi-Stage platform trials in progress

Multi-Arm Multi-Stage (MAMS) platform trials are an efficient tool for t...
research
11/28/2017

A two-stage Fisher exact test for multi-arm studies with binary outcome variables

In small sample studies with binary outcome data, use of a normal approx...
research
05/19/2022

Adaptive Experiments and a Rigorous Framework for Type I Error Verification and Computational Experiment Design

This PhD thesis covers breakthroughs in several areas of adaptive experi...
research
12/01/2017

Efficient determination of optimised multi-arm multi-stage experimental designs with control of generalised error-rates

Primarily motivated by the drug development process, several publication...
research
12/04/2020

Optimal Bayesian hierarchical model to accelerate the development of tissue-agnostic drugs and basket trials

Tissue-agnostic trials enroll patients based on their genetic biomarkers...

Please sign up or login with your details

Forgot password? Click here to reset